rs148071928

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_173551.5(ANKS6):​c.1565A>G​(p.Asn522Ser) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00258 in 1,614,068 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 18/24 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0022 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0026 ( 6 hom. )

Consequence

ANKS6
NM_173551.5 missense, splice_region

Scores

19
Splicing: ADA: 0.0004231
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.332

Publications

7 publications found
Variant links:
Genes affected
ANKS6 (HGNC:26724): (ankyrin repeat and sterile alpha motif domain containing 6) This gene encodes a protein containing multiple ankyrin repeats and a SAM domain. It is thought that this protein may localize to the proximal region of the primary cilium, and may play a role in renal and cardiovascular development. Mutations in this gene have been shown to cause a form of nephronophthisis (NPHP16), a chronic tubulo-interstitial nephritis. [provided by RefSeq, Jul 2015]
ANKS6 Gene-Disease associations (from GenCC):
  • nephronophthisis 16
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • nephronophthisis 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • nephronophthisis 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0037843883).
BP6
Variant 9-98778228-T-C is Benign according to our data. Variant chr9-98778228-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 541404.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANKS6NM_173551.5 linkc.1565A>G p.Asn522Ser missense_variant, splice_region_variant Exon 7 of 15 ENST00000353234.5 NP_775822.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANKS6ENST00000353234.5 linkc.1565A>G p.Asn522Ser missense_variant, splice_region_variant Exon 7 of 15 1 NM_173551.5 ENSP00000297837.6
ANKS6ENST00000375019.6 linkc.662A>G p.Asn221Ser missense_variant, splice_region_variant Exon 6 of 15 5 ENSP00000364159.2
ANKS6ENST00000634393.1 linkn.665A>G splice_region_variant, non_coding_transcript_exon_variant Exon 5 of 15 5

Frequencies

GnomAD3 genomes
AF:
0.00225
AC:
342
AN:
152142
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000386
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00499
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00375
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00262
AC:
652
AN:
249252
AF XY:
0.00276
show subpopulations
Gnomad AFR exome
AF:
0.000388
Gnomad AMR exome
AF:
0.000870
Gnomad ASJ exome
AF:
0.000696
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00478
Gnomad NFE exome
AF:
0.00429
Gnomad OTH exome
AF:
0.00281
GnomAD4 exome
AF:
0.00261
AC:
3816
AN:
1461808
Hom.:
6
Cov.:
31
AF XY:
0.00257
AC XY:
1870
AN XY:
727194
show subpopulations
African (AFR)
AF:
0.000388
AC:
13
AN:
33476
American (AMR)
AF:
0.000939
AC:
42
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.000383
AC:
10
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.000232
AC:
20
AN:
86252
European-Finnish (FIN)
AF:
0.00511
AC:
273
AN:
53418
Middle Eastern (MID)
AF:
0.00156
AC:
9
AN:
5766
European-Non Finnish (NFE)
AF:
0.00298
AC:
3313
AN:
1111958
Other (OTH)
AF:
0.00225
AC:
136
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
216
432
649
865
1081
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00225
AC:
342
AN:
152260
Hom.:
1
Cov.:
32
AF XY:
0.00227
AC XY:
169
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.000385
AC:
16
AN:
41550
American (AMR)
AF:
0.000588
AC:
9
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4808
European-Finnish (FIN)
AF:
0.00499
AC:
53
AN:
10616
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00375
AC:
255
AN:
68014
Other (OTH)
AF:
0.00237
AC:
5
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
18
35
53
70
88
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00306
Hom.:
4
Bravo
AF:
0.00185
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.00156
AC:
6
ESP6500AA
AF:
0.00102
AC:
4
ESP6500EA
AF:
0.00337
AC:
28
ExAC
AF:
0.00324
AC:
392
EpiCase
AF:
0.00463
EpiControl
AF:
0.00373

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Nephronophthisis 16 Benign:1
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Oct 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ANKS6: BP4 -

ANKS6-related disorder Benign:1
Sep 08, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.053
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
2.7
DANN
Benign
0.24
DEOGEN2
Benign
0.0056
.;T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.017
N
LIST_S2
Benign
0.69
T;T
M_CAP
Benign
0.016
T
MetaRNN
Benign
0.0038
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.41
.;N
PhyloP100
-0.33
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-0.28
N;N
REVEL
Benign
0.029
Sift
Benign
1.0
T;T
Sift4G
Benign
1.0
T;T
Polyphen
0.0030
.;B
Vest4
0.15
MVP
0.29
MPC
0.080
ClinPred
0.00081
T
GERP RS
-1.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.6
Varity_R
0.022
gMVP
0.060
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00042
dbscSNV1_RF
Benign
0.19
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148071928; hg19: chr9-101540510; API